267 results on '"Wittner, Ben S."'
Search Results
2. Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
3. DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs
4. TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state
5. Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
6. CDKN1B(p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors
7. Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA
8. COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis
9. Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy
10. HIF1A signaling selectively supports proliferation of breast cancer in the brain
11. Abstract CT073: Efficacy of novel oral SERD elacestrant in fulvestrant-refractory hormone receptor-positive (HR+) breast cancer: a translational investigation
12. Data from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
13. Table S2 from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
14. Supplementary Tables from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
15. Data from AR Expression in Breast Cancer CTCs Associates with Bone Metastases
16. Supplementary figures from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
17. Figure S6 from MAPK7 Regulates EMT Features and Modulates the Generation of CTCs
18. Data from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
19. Supplementary Tables from AR Expression in Breast Cancer CTCs Associates with Bone Metastases
20. Data from Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
21. Supplementary Data from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
22. Supplementary methods from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
23. Supplementary Methods from Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
24. Supplementary Figures S1 - S10 from AR Expression in Breast Cancer CTCs Associates with Bone Metastases
25. Data from MAPK7 Regulates EMT Features and Modulates the Generation of CTCs
26. Supplementary Tables 1-2 from Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
27. Supplementary Figures 1-6 from Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
28. Supplemental Methods, Tables S1-2, Table Legends and Figure Legends from MAPK7 Regulates EMT Features and Modulates the Generation of CTCs
29. Data from Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
30. Supplementary Table S1 from Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
31. Abstract IA010: Hypomethylation of immune-related loci contribute to prostate tumorigenesis
32. Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer
33. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
34. Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
35. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
36. Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition
37. Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
38. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
39. Asymmetric cancer cell division regulated by AKT
40. MYC Regulation of a "Poor-Prognosis" Metastatic Cancer Cell State
41. Antiestrogen-Resistant Subclones of MCF-7 Human Breast Cancer Cells Are Derived from a Common Monoclonal Drug-Resistant Progenitor
42. NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer
43. PROSTATE CANCER: RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
44. A Proof of the Uniformization Theorem for Arbitrary Plane Domains
45. The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
46. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis
47. CANCER THERAPY: Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
48. Single cell proteomics of tumor compartments identifies differential kinase activities defining sensitivity to mTOR-PI3-kinase inhibition
49. HER2 expression identifies dynamic functional states within circulating breast cancer cells
50. Abstract 6073: The lipogenic regulatorSREBPinducesTransferrinin circulating melanoma cells, suppressing their susceptibility to ferroptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.